207 related articles for article (PubMed ID: 2057177)
1. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
Krikorian A; Breillout F
Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
[TBL] [Abstract][Full Text] [Related]
2. Advances in vinca-alkaloids: Navelbine.
Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
[TBL] [Abstract][Full Text] [Related]
3. Summary of data from in vitro and phase I vinorelbine (Navelbine) studies.
Burris HA; Fields S
Semin Oncol; 1994 Oct; 21(5 Suppl 10):14-9; discussion 19-20. PubMed ID: 7973764
[TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
[TBL] [Abstract][Full Text] [Related]
6. Vinorelbine: a novel vinca alkaloid.
Toso C; Lindley C
Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
[TBL] [Abstract][Full Text] [Related]
8. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
Coltman CA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine (Navelbine): a third-generation vinca alkaloid.
Budman DR
Cancer Invest; 1997; 15(5):475-90. PubMed ID: 9316630
[TBL] [Abstract][Full Text] [Related]
11. Phase I pharmacologic study of a new Vinca alkaloid: navelbine.
Mathé G; Reizenstein P
Cancer Lett; 1985 Jul; 27(3):285-93. PubMed ID: 4016723
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
13. Vinorelbine tartrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid.
Brogden JM; Nevidjon B
Oncol Nurs Forum; 1995 May; 22(4):635-46. PubMed ID: 7675666
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
Crawford J; O'Rourke MA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer.
Edelstein MP; Wolfe LA; Duch DS
Semin Oncol; 1996 Apr; 23(2 Suppl 5):41-7. PubMed ID: 8610236
[TBL] [Abstract][Full Text] [Related]
16. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
Kruczynski A; Hill BT
Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine (Navelbine) in the treatment of breast cancer: a summary.
Abeloff MD
Semin Oncol; 1995 Apr; 22(2 Suppl 5):1-4; discussion 41-4. PubMed ID: 7740330
[TBL] [Abstract][Full Text] [Related]
18. Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
Winer EP; Chu L; Spicer DV
Semin Oncol; 1995 Apr; 22(2 Suppl 5):72-8; discussion 78-9. PubMed ID: 7740337
[TBL] [Abstract][Full Text] [Related]
19. Activity of vinorelbine in gastrointestinal cancers.
Conroy T
Crit Rev Oncol Hematol; 2002 May; 42(2):173-8. PubMed ID: 12007975
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine. A review of its antitumour activity in lung cancer.
Sørensen JB
Drugs; 1992; 44 Suppl 4():60-5; discussion 66-9. PubMed ID: 1283851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]